Free Republic

It didn’t matter that Eric Tennant’s oncologist had recommended the medication to shrink his tumors. The patient’s health insurance allegedly stood in the way — until it was too late. In early 2025, after more than two years of chemotherapy that hollowed him out from the inside, the frail 58-year-old was deemed a good candidate for histotripsy, a new treatment that could target the tumors in his liver with ultrasound waves instead of surgery. Tennant’s wife, Rebecca, had heard of histotripsy and brought the idea to her husband’s doctor. There was a relatively narrow window in which he could receive...

From the very beginning of the CV19 bioweapon vax rollout in 2021, Dr. Betsy Eads (aka Dr. Betsy) sounded the alarm on all the severe medical problems, disabilities and deaths the injections would cause. Dr. Betsy has been promoting constant detoxing from the shots. In July, she, once again, pushed the idea that “Everyone Needs Treatment for CV19 Bioweapon Vax.” For the CV19 vaxed who are untreated, it is a total disaster. Just look at the out-of-control cancer numbers that Dr. Betsy said were coming back in 2021. Dr. Betsy says, “I gave you some predictions. I told you that...

Leonid Radvinsky, the ​owner of adult‑content ‌platform OnlyFans, has died of ​cancer at ​the age of 43, ⁠the company ​said in a ​statement on Monday. "We are deeply saddened ​to announce ​the death of Leo ‌Radvinsky. ⁠Leo passed away peacefully after a long battle ​with ​cancer," ⁠an OnlyFans spokesperson said. "His ​family have ​requested ⁠privacy at this difficult ⁠time." SNP

President Trump has just announced that White House chief of staff Susie Wiles has been diagnosed with “early stage breast cancer.” “She has a fantastic medical team, and her prognosis is excellent!,” Trump wrote on Truth Social. “During the treatment period, she will be spending virtually full time at the White House, which makes me, as President, very happy! “Her Strength and her Commitment to continue doing the job she loves, and does so well, while undergoing treatment, tells you everything you need to know about her. “Susie, as one of my closest and most important advisors, is tough and...

A tech entrepreneur has created a personalised cancer vaccine for his dog, a breakthrough experts say could shape the future of human medicine. Sydney man Paul Conyngham adopted his 'best mate' Rosie, an eight-year-old staffy-Shar Pei cross in 2019. In 2024, the canine was diagnosed with mast cell cancer after large tumours started to appear on one of her back legs. Mast cell cancer is the most common skin cancer found in dogs, and often appears as lumps, nodules or masses in the skin. Mr Conyngham spent thousands on veterinary chemotherapy for Rosie, which slowed the spread of the tumours...

Wall Street Apes@WallStreetApes·4hI verified this and it’s true“This is a class Group 1 carcinogen. The new study warns there's NO SAFE amount of ham, bacon, or even pepperoni for human consumption”Processed meats including ham, bacon, pepperoni are now definitively linked to cancer (Group 1), and newer 2025–2026 studies reinforce thee is no “safe” level that exists for regular consumption“One flimsy cut is lubricated with over 28 bio stabilizers. It's an ammonia-washed paste glued together with synthetic hydrocolloids. That color is then artificially enforced with a corrosive rust inhibitor called sodium nitrite. Group 1 carcinogen that ranks on the same pedestal...

A newly surfaced CIA document suggests US intelligence once reviewed research that hinted at a possible cancer treatment more than 60 years ago. The document, produced in February 1951 and declassified in 2014, summarizes a Soviet scientific paper that examined striking similarities between parasitic worms and cancerous tumors. snip Although the document was declassified more than a decade ago, it has recently resurfaced online, fueling outrage among some Americans who say it raises troubling questions about why Cold War research hinting at possible cancer treatments sat in intelligence archives for decades.

Senator John Fetterman (D-PA) spoke out against a deal with Iran, referring to the Islamic Republic as a “cancer". His comments came in an interview with Fox News, amid tensions between the US and Iran. “How could you allow Iran to acquire a nuclear bomb? Now, people have always said that. Well, you know, [President Donald Trump] actually did something to actually prevent Iran from doing that," said Fetterman. “If they have 900 pounds of near weapons-grade uranium why wouldn't you strike that? Why wouldn't you hold them accountable that way? And now here we are again, and now we've...

Just last night, I received some sad news about Nick Pope. He published a brief message that said: A while ago, following some digestive issues, I was diagnosed with esophageal cancer. Unfortunately, it's Stage 4 and has metastasized to my liver. While I know that it's kindness and hope that leads people to suggest healers and supposed miracle cures, and to say things like "fight it", and "you can beat it", I'm afraid my diagnosis and my situation leaves no doubt whatsoever: I can't beat it.

For most of the 20th century, scientists pictured the immune system as the body’s ever-vigilant army—standing guard against germs, viruses, and rogue cells. Yet one question remained: What keeps this army from mistakenly attacking the body itself? For millions with autoimmune and inflammatory diseases like Type 1 diabetes or lupus, the question is personal—these lifelong illnesses bring painful symptoms and harsh immune-suppressing treatments. This year’s Nobel Prize in Physiology or Medicine honored the discoveries that transformed that understanding. Researchers Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi identified a rare class of immune cells—regulatory T cells, or Tregs. These cells...

A sweeping new report from the World Health Organization found that up to four in 10 cancer cases around the globe could be prevented with lifestyle changes. In the large international study, researchers identified 30 modifiable risk factors that fuel the disease — including, for the first time, nine cancer-causing infections. “This is the first global analysis to show how much cancer risk comes from causes we can prevent,” Dr. André Ilbawi, the WHO’s team lead for cancer control and the study’s author, said in a press release. “By examining patterns across countries and population groups, we can provide governments...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized phase 3 trial of 210 participants, suggest that scheduling therapy early in the day may offer a simple, cost-neutral way to enhance standard care. Circadian rhythms, the internal 24-hour clock, are known to affect immune cell behavior and responses to treatment. Previous retrospective studies across cancers, such as kidney cancer and malignant melanoma, have hinted that administering immune checkpoint inhibitors earlier in the day might be...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A study has found that low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer. When people consume protein, the nitrogen can be converted into ammonia, a substance that's toxic to the body and brain. A healthy liver typically processes this ammonia into harmless urea, which is excreted via urine. To test whether impaired ammonia processing drives cancer...

A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, focused on the circadian protein Cryptochrome1 (CRY1), suggests that the time of day when radiotherapy is administered can significantly influence the effectiveness of treatment for certain types of cancer. It is relatively common for cancer cells to be unable to repair their DNA efficiently. Treatments, such as radiotherapy, exploit this by generating DNA breaks that tumor cells are unable to repair. This study shows DNA break repair in human cells exhibits a circadian oscillation. In a...

For decades, pancreatic cancer has been one of medicine's most feared diagnoses. Aggressive, fast moving, and stubbornly resistant to treatment, it has claimed lives with ruthless efficiency. Now, the name Mariano Barbacid is echoing far beyond scientific circles. His latest work is being hailed as one of the most important cancer breakthroughs in years, offering a glimmer of hope against a disease that has defied progress for decades. Who Is Mariano Barbacid Mariano Barbacid was born on 4 October 1949 and built his career at the cutting edge of cancer genetics. He earned his PhD from the Universidad Complutense de...

Pancreatic cancer is one of the most aggressive tumours with the worst prognosis, partly because of the rapid emergence of resistance to treatment. But a new study from the Spanish National Cancer Research Centre (CNIO) reveals that it is possible to eliminate pancreatic tumours in mice and prevent them from recurring using triple combination therapy. "These studies open a way to design new combination therapies that can improve the survival of patients with pancreatic ductal adenocarcinoma," the authors said in a statement. "These results set the direction for the development of new clinical trials, it added. The results, published in...

Scientists have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor). In a study, the researchers reveal a previously unknown survival mechanism and demonstrated that disrupting it can shrink tumors in laboratory models. Lung cancer is the leading cause of cancer deaths globally. Many cases are driven by mutations in the EGFR gene. These mutations are found in up to 40–60% of adenocarcinoma. The researchers screened more than 21,000 genes to identify what protects these mutant proteins from being broken down. They discovered that cancer...

For the first time, most people diagnosed with cancer are expected to live at least five years beyond their diagnosis—a dramatic improvement from previous decades. The improvements detailed in the organization’s Cancer Statistics 2026 report, recently published in CA: A Cancer Journal for Clinicians, highlight significant progress in cancer survival rates in the United States. “Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” Rebecca Siegel, senior scientific director at the American Cancer Society (ACS), said in a press statement. She credited decades of cancer research that have provided doctors...

SNIP The “Dilbert” creator, 68, is reportedly in hospice at his home in Northern California, his first ex-wife, Shelly Miles, told TMZ on Monday. Miles, who was married to the legendary cartoonist from 2006 to 2014, also informed the outlet that Adams began receiving “end-of-life care” at his home last week because his health was declining “rapidly.” Although nurses have reportedly been “coming in and out” around the clock, Miles said that she, her sister and the “Dilbert” creator’s stepdaughter, Savannah, have been helping to care for Adams in his final days.

A global review examining reported cases of cancer following Covid vaccination was published earlier this month, just as the medical journal hosting it was hit by a cyberattack that has since taken the site offline.The study appeared in the peer-reviewed journal Oncotarget on January 3 and was authored by cancer researchers from Tufts University in Boston and Brown University in Rhode Island.In the review, researchers analyzed 69 previously published studies and case reports from around the world, identifying 333 instances in which cancer was newly diagnosed or rapidly worsened within a few weeks following Covid vaccination.The review covered studies from...